Clinical Trial Update: Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Niraparib in combination with Panitumumab in advanced or metastatic microsatellite-stable colorectal cancer; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)
• Zejula (Niraparib)

Snippet

Sponsor: Emory University | Conditions: Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-09